Industry Insights
Industry Insights, October 26, 2026
A device trial should end with a clear decision. Too often it ends with ambiguity. The trial ran, some cases happened, opinions are mixed, and the facility is no closer to knowing whether to adopt than before it started. A trial that does not produce a decision is wasted time and effort. Structuring the trial… Continue reading How to Run a Device Trial Period That Produces a Clear Decision
Industry Insights, October 22, 2026
Timing separates the franchise owners who close from the ones who stall. Push too early, and you damage a relationship that was not ready. Wait too long, and you lose momentum as a competitor picks up. Reading a facility's buying signals, the cues that tell you where a relationship stands, is how you know when… Continue reading Read a Facility’s Buying Signals and Know When to Advance
Industry Insights, October 19, 2026
A new device clears FDA review, and the instinct is to launch everywhere immediately. Capture the whole market before competitors react. That instinct is understandable and usually wrong. A phased geographic rollout, launching in selected markets first and expanding deliberately, produces stronger adoption, cleaner feedback, and more sustainable growth than a simultaneous national launch that… Continue reading Phased Geographic Rollout Beats Launching Everywhere at Once
Industry Insights, October 15, 2026
You know the device well. You have run the procedure hundreds of times. But the scrub team in front of you today is new, and they do not know your preferences, your pace, or the instrument sequence the way your usual team does. The device is familiar. The team is not. That mismatch is a… Continue reading How to Work Effectively With a New Scrub Team on a Device You Know Well
Industry Insights, October 12, 2026
Medical device sales rewards availability. Cases happen early, run late, and arrive on short notice. A franchise owner building a territory can easily fall into a pattern of being available for everything, all the time, until the pace becomes unsustainable. The franchise owners who build lasting territories do it on a routine they can maintain… Continue reading Build a Weekly Routine That Sustains a Growing Territory
Industry Insights, October 8, 2026
You have selected a new distributor. The contract is signed. Now the relationship has to become operational, and how you handle onboarding determines how quickly the distributor starts delivering value and how much administrative friction the process creates. A structured onboarding gets the relationship productive fast. An unstructured one creates weeks of back-and-forth before the… Continue reading How to Onboard a New Distributor Relationship Efficiently
Industry Insights, October 5, 2026
A cadaver lab or device demonstration is designed to show a product at its best. The setup is ideal. The tissue is prepared. The instructor knows every step. That controlled environment is useful for learning technique, but it is not the same as your OR with your patients. Evaluating a demonstration critically means separating what… Continue reading Evaluate a Device Demonstration or Cadaver Lab Before You Adopt
Industry Insights, September 30, 2026
FDA clearance gets a device to market. Post-market clinical data keeps it there and helps it grow. The evidence a device accumulates after launch, real-world outcomes, published studies, registry data, is among the most powerful tools a manufacturer has to drive adoption. Yet many manufacturers treat post-market data as a regulatory obligation rather than a… Continue reading How Post-Market Clinical Data Strengthens Your Distribution Position
